It was reported that: the physicians deployed an 18fr manta device over a j wire.Patient had unstable blood pressure post deployment and a retroperitoneal bleed was discovered.Additional information on 10mar2023: during a tavr procedure on 20feb the cardiac tech stated that they realized the patient had a rp bleed post procedure when patient became hypotensive.Acute cardiac life support (i.E., cpr, emergency ivp medications like epinephrine, lidocaine, etc) was performed.The tech stated that 6 units of blood were given.Cpr was initiated.The patient is reported as critical post procedure.Additional information has been requested from the account.A follow up report will be submitted after receipt of this information.
|
(b)(4).The device was not returned for investigation.No return product evaluation could be completed.The device lot number was not reported for this investigation.Based on the information submitted, following an tavr procedure, a 18f manta was deployed for closure.Post-deployment the patient's blood pressure was unstable, became hypotensive, and a retroperitoneal bleed was discovered.Cpr was initiated, advanced cardiovascular life support performed, and the patient received six units of packed blood cells.Due to no information regarding the initial and deployment procedures, patient conditions and environment, no device or angiograms submitted for investigative purposes, a root cause of the retroperitoneal bleed remains undeterminable.This physician has not completed manta training and it is unknown how many manta cases this physician has performed.No manta representative and no manta trained healthcare professional were mentioned being present for this procedure.The ifu posts caution: federal law restricts this device to sale by or on the order of a physician (or allied healthcare professionals, authorized by, or under the direction of, such physicians) who is trained in interventional catheterization procedures and who has been trained in manta device use by an authorized representative of essential medical.Precautions the manta device should only be used by a licensed physician or healthcare provider trained in the use of this device.Potential adverse events as listed in the ifu, related to the deployment of vascular closure devices include retroperitoneal bleeding, and its consequences, because of failed closure in the setting of an access above the inguinal ligament or the most inferior border of the epigastric artery (iea).
|
It was reported that: the physicians deployed an 18fr manta device over a j wire.Patient had unstable blood pressure post deployment and a retroperitoneal bleed was discovered.Additional information on 10mar2023: during a tavr procedure on (b)(6) the cardiac tech stated that they realized the patient had a rp bleed post procedure when patient became hypotensive.Acute cardiac life support (i.E., cpr, emergency ivp medications like epinephrine, lidocaine, etc) was performed.The tech stated that 6 units of blood were given.Cpr was initiated.The patient is reported as critical post procedure.Additional information has been requested from the account.A follow up report will be submitted after receipt of this information.
|